Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?

被引：124

作者：

Pinheiro, Ruben G. R. ^{[1
]}

Coutinho, Ana Joyce ^{[1
]}

Pinheiro, Marina ^{[1
]}

Neves, Ana Rute ^{[1
,2
]}

机构：

[1] Univ Porto, LAQV, REQUIMTE, Dept Ciencias Quim,Fac Farm, Rua Jorge Viterbo Ferreira 228, P-4050313 Porto, Portugal

[2] Univ Madeira, CQM Ctr Quim Madeira, Campus Penteada, P-9020105 Funchal, Portugal

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 21期

关键词：

Alzheimer's disease; drug delivery; drug targeting; neurodegenerative diseases; Parkinson's disease; SOLID LIPID NANOPARTICLES; PEG-PLA NANOPARTICLES; NICOTINIC ACETYLCHOLINE-RECEPTORS; IIB-IIIA COMPLEX; PLGA NANOPARTICLES; IN-VITRO; LOADED NANOPARTICLES; GLUCOSE TRANSPORTERS; TRANSFERRIN-RECEPTOR; TUMOR VASCULATURE;

D O I：

10.3390/ijms222111654

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The blood-brain barrier (BBB) is a barrier that separates the blood from the brain tissue and possesses unique characteristics that make the delivery of drugs to the brain a great challenge. To achieve this purpose, it is necessary to design strategies to allow BBB passage, in order to reach the brain and target the desired anatomic region. The use of nanomedicine has great potential to overcome this problem, since one can modify nanoparticles with strategic molecules that can interact with the BBB and induce uptake through the brain endothelial cells and consequently reach the brain tissue. This review addresses the potential of nanomedicines to treat neurological diseases by using nanoparticles specially developed to cross the BBB.

引用

页数：22

共 50 条

[31] Polysorbate-Based Drug Formulations for Brain-Targeted Drug Delivery and Anticancer Therapy
Ravichandran, Vasanthan
Lee, Minjong
Thuy Giang Nguyen Cao
Shim, Min Suk
APPLIED SCIENCES-BASEL, 2021, 11 (19):
[32] Paradoxical side effects of bisphosphonates on the skeleton: What do we know and what can we do?
Vargas-Franco, Jorge W.
Castaneda, Beatriz
Redini, Francoise
Gomez, David F.
Heymann, Dominique
Lezot, Frederic
JOURNAL OF CELLULAR PHYSIOLOGY, 2018, 233 (08) : 5696 - 5715
[33] Germination of Spores of Bacillus Species: What We Know and Do Not Know
Setlow, Peter
JOURNAL OF BACTERIOLOGY, 2014, 196 (07) : 1297 - 1305
[34] Nanocarriers for Effective Brain Drug Delivery
Comoglu, Tansel
Arisoy, Sema
Akkus, Zeynep Burcu
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (13) : 1490 - 1506
[35] Recent progresses in exosome-based systems for targeted drug delivery to the brain
Bashyal, Santosh
Thapa, Chhitij
Lee, Sangkil
JOURNAL OF CONTROLLED RELEASE, 2022, 348 : 723 - 744
[36] Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis
Ghosh, Maitrayee
Roy, Debajyoti
Thakur, Shubham
Singh, Amrinder
BIOPHARMACEUTICS & DRUG DISPOSITION, 2024, : 161 - 189
[37] Polymeric nanoparticles for targeted drug delivery system for cancer therapy
Masood, Farha
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2016, 60 : 569 - 578
[38] What do we know about the inflammasome in humans?
Amin, Jay
Boche, Delphine
Rakic, Sonja
BRAIN PATHOLOGY, 2017, 27 (02) : 192 - 204
[39] Bacterial Vaginosis: What Do We Currently Know?
Abou Chacra, Linda
Fenollar, Florence
Diop, Khoudia
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 11
[40] Dengue Virus Glycosylation: What Do We Know?
Yap, Sally S. L.
Nguyen-Khuong, Terry
Rudd, Pauline M.
Alonso, Sylvie
FRONTIERS IN MICROBIOLOGY, 2017, 8

← 1 2 3 4 5 →